Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease
BiomX has acquired RondinX, expanding its bacterial target discovery platform and adding new microbiome targets…
December 20, 2017 - 2 minutes
Microbiome: An Emerging Field with Growing Investments
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Show More
Editor's Picks for Microbiome
- UK Startup Surfs Investment Wave in Microbiome with €18M Series A
- Microbiome Medicines Could Power Up CAR-T Cell Therapies
- Investing in the Microbiome in the Age of Covid-19 and Beyond
- The Missing Piece in the Microbiome Field
- No Guts, No Glory: How Microbiome Research is Changing Medicine
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportLatest Microbiome Articles
Qiagen Joins French Biotech to Build the Next Generation of Microbiome Technology
Biomillenia harnesses the power of bacteria to keep the body healthy. The biotech has joined…
November 30, 2017 - 3 minutes
French Microbiome Biotech Gets a €6.5M Leg Up to Market Launch
LNC Therapeutics is ready to take its oral microbiome-based therapeutic to market for obesity. Investors…
September 28, 2017 - 2 minutes
French Biotech Gets $20M to Treat the Microbiome with CRISPR Nanobots
Eligo Bioscience has announced its first fundraising round, amassing $20M (€18.5M) that will be put…
September 26, 2017 - 3 minutes
EU gives French Biotech €20M to Continue the Fight Against Antibiotic Resistance
Da Volterra has been boosted by a €20M loan to speed up the development of solutions…
September 22, 2017 - 3 minutes
Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A
Bayer and Ginkgo Bioworks are launching a new company that will develop new technologies for…
September 15, 2017 - 2 minutes
The Music of the Microbiome Questions our Identity as Humans
Slovenian artists Saša Spačal, Mirjan Švagelj and Anil Podgornik explore the meaning of human identity by…
September 9, 2017 - 3 minutes
Enterome and Nestle Launch a New Microbiome Diagnostics Company
Microbiome Diagnostics Partners will develop diagnostics tests with Enterome's microbiome platform IP and a €20M…
July 11, 2017 - 1 minute
Better than CRISPR? New Genetic Analysis Method ropes in Long-Read DNA Cloning
After CRISPR, there's a new genetic technique with a tongue-in-cheek name in town: LASSO cloning. …
July 7, 2017 - 3 minutes
This Company Uses the Human Microbiome to Discover New Disease Mechanisms
A whole new avenue to human health and disease could soon be accessible, thanks to…
June 19, 2017 - 5 minutes
Why Should we be Excited about the Emerging Microbiome Field?
A panel of experts at Microbiome Invest in London discussed the unlimited applications of the microbiome and how…
June 1, 2017 - 4 minutes
Curious about Who is Living in Your Gut? This Kit Can Tell You
Personalized and democratized medicine is coming to the microbiome via a new initiative, FeelGut, from…
May 24, 2017 - 3 minutes
